Retour sur lavenir.net
   MELEXIS 65.650 € (+2,90 %)     SYENSQO 79.950 € (-1,60 %)     AEDIFICA 69.250 € (+0,36 %)     AB INBEV 67.820 € (-1,11 %)     FAGRON 22.450 € (+0,67 %)     SOLVAC NOM(RETAIL) 85.000 € (+3,03 %)     KBC 133.100 € (+0,41 %)     TUBIZE-FIN 190.900 € (+1,33 %)     BARCO 7.770 € (+0,78 %)     CMB.TECH 15.660 € (+0,77 %)     LOTUS BAKERIES 13 080.000 € (+0,62 %)     SHURGARD 23.550 € (+0,21 %)     AZELIS GROUP 12.010 € (-0,25 %)     ARGENX SE 872.800 € (+1,00 %)     ECONOCOM GROUP 1.465 € (-2,33 %)     CENERGY 22.840 € (+4,67 %)     GBL 73.550 € (-0,14 %)     HYLORIS 4.420 € (-0,90 %)     WERELDHAVE BELGIUM 52.000 € (-0,38 %)     UMICORE 23.300 € (-0,26 %)     EKOPAK 3.710 € (-0,54 %)     UCB 223.100 € (+1,41 %)     COLRUYT 39.420 € (-0,35 %)     KINEPOLIS GROUP 46.100 € (+0,55 %)     DEME GROUP 170.000 € (+0,12 %)     WDP 21.560 € (+0,09 %)     TITAN S.A. 51.750 € (+2,58 %)     EVS 30.050 € (+0,33 %)     CARE PROPERTY INV. 12.240 € (-0,16 %)     SOLVAY 25.580 € (0,00 %)     KBC ANCORA 94.400 € (+0,43 %)     BPOST 1.320 € (0,00 %)     VGP 82.500 € (+0,98 %)     ATENOR 1.295 € (+4,44 %)     SOFINA 244.000 € (-0,41 %)     BEKAERT 37.900 € (+0,80 %)     TESSENDERLO 20.850 € (+0,97 %)     MONTEA 66.900 € (0,00 %)     XIOR 27.200 € (+0,37 %)     AGEAS 74.050 € (+0,89 %)     DECEUNINCK 2.415 € (+0,42 %)     FLUXYS BELGIUM D 20.400 € (+1,49 %)     PROXIMUS 6.285 € (+1,21 %)     ELIA GROUP 127.100 € (+0,71 %)     JENSEN-GROUP 73.800 € (+4,53 %)     NYXOAH 1.446 € (+1,12 %)     ONTEX GROUP 2.675 € (+1,52 %)     ONWARD MEDICAL 2.310 € (+0,87 %)     SIPEF 103.400 € (+0,58 %)     ACKERMANS V.HAAREN 259.200 € (+0,78 %)     D'IETEREN GROUP 176.600 € (0,00 %)     NYRSTAR 0.060 € (0,00 %)     CELYAD ONCOLOGY 0.256 € (-2,29 %)     BANQUP GROUP 1.900 € (-8,21 %)     VAN DE VELDE 29.600 € (+0,34 %)     IBA 16.000 € (+1,01 %)     AGFA-GEVAERT 0.420 € (0,00 %)     RECTICEL 12.860 € (+2,06 %)     GIMV 44.150 € (-0,45 %)     BIOTALYS 2.680 € (-1,47 %)  
   PLANISWARE 24.900 € (0,00 %)     FDJ UNITED 22.260 € (-0,45 %)     ATON 0.021 € (+23,53 %)     STMICROELECTRONICS 42.735 € (+1,22 %)     ASM INTERNATIONAL 833.200 € (+1,31 %)     ASML HOLDING 1 511.600 € (+1,46 %)     AIR FRANCE -KLM 12.220 € (+5,12 %)     HERMES INTL 1 578.000 € (-0,16 %)     BNP PARIBAS ACT.A 105.900 € (-0,84 %)     PULLUP ENTERTAIN 8.600 € (+2,50 %)     TECHNIP ENERGIES 29.740 € (+1,50 %)     2CRSI 27.400 € (+3,55 %)     AIRBUS 206.950 € (+2,10 %)     X-FAB 6.070 € (+6,03 %)     BE SEMICONDUCTOR 201.100 € (-3,32 %)     RANDSTAD NV 39.650 € (+0,03 %)     SARTORIUS STED BIO 193.100 € (+0,99 %)     SBM OFFSHORE 34.080 € (+1,25 %)     PROSUS 37.520 € (-0,68 %)     L'OREAL 387.950 € (-1,16 %)     MAGNUM 17.232 € (-1,15 %)     AMG 31.920 € (+0,88 %)     EUTELSAT COMMUNIC. 1.884 € (+1,02 %)     EUROFINS SCIENT. 73.800 € (+0,74 %)     ING GROEP N.V. 30.230 € (+0,63 %)     SOCIETE GENERALE 75.780 € (+0,19 %)     SAINT GOBAIN 81.260 € (+1,27 %)     CREDIT AGRICOLE 19.140 € (+0,29 %)     EDP 4.676 € (+0,86 %)     EIFFAGE 118.750 € (+1,15 %)     CTP 14.500 € (+1,12 %)     DANONE 66.100 € (-0,06 %)     B.COM.PORTUGUES 1.114 € (+1,50 %)     BUREAU VERITAS 28.010 € (+0,61 %)     TME PHARMA 0.133 € (-14,74 %)     ARCELORMITTAL SA 63.040 € (+0,38 %)     SCHNEIDER ELECTRIC 297.600 € (+1,99 %)     TOTALENERGIES 75.850 € (-0,17 %)     DBV TECHNOLOGIES 2.546 € (+4,43 %)     DASSAULT SYSTEMES 22.500 € (-0,71 %)     FLOW TRADERS 29.260 € (+0,48 %)     AB SCIENCE 0.760 € (+13,10 %)     VINCI 119.650 € (+0,84 %)     RENAULT 27.450 € (-3,04 %)     AHOLD DEL 31.300 € (-0,25 %)     SHELL PLC 39.535 € (-0,60 %)     HEINEKEN 72.860 € (-1,01 %)     WOLTERS KLUWER 70.280 € (-1,98 %)     VIRIDIEN 86.650 € (+1,35 %)     EXOSENS 61.350 € (+2,25 %)     EMEIS 14.000 € (-0,50 %)     CHRISTIAN DIOR 410.800 € (-0,77 %)     PHILIPS KON 23.590 € (-0,08 %)     LVMH 455.300 € (-0,88 %)     EXAIL TECHNOLOGIES 124.400 € (-0,08 %)     UNILEVER 55.290 € (-1,14 %)     THEON INTERNAT 33.960 € (-0,12 %)     PERNOD RICARD 67.820 € (-1,71 %)     VEOLIA ENVIRON. 34.190 € (+0,47 %)     WERELDHAVE 18.600 € (+0,87 %)  
News Réglementées
29/07/2026 09:16

Original-Research: GFT Technologies SE (von NuWays AG): BUY

Original-Research: GFT Technologies SE - from NuWays AG

29.07.2026 / 09:16 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to GFT Technologies SE

Company Name:GFT Technologies SE
ISIN:DE0005800601
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 32
Target price on sight of:12 months
Last rating change:
Analyst:Simon Keller

Q2 set to confirm earnings acceleration

GFT reports H1 results on 6 August, and we expect a second consecutive quarter of adj. EBIT growing well ahead of sales. The recent IBM and Accenture news do not read across to GFT, in our view, while two takeovers of listed peers highlight the structural attractiveness of the sector at current prices.

Q2 sales look set to improve 4.5% yoy to € 229.5m and adj. EBIT is seen growing 8.6% yoy to € 16.3m, at a margin of 7.1% (+0.3pp yoy; eNuW). That would mark a second consecutive quarter of earnings growing well ahead of sales, with the pace picking up from Q1 (adj. EBIT +6.8% yoy). The mix should look much like Q1, with double-digit growth in the Americas on the back of strong business in Brazil, a still soft Germany, and a UK business having just passed the trough.

On our estimates, H1 would account for c. 49% of FY sales and c. 46% of the adj. EBIT guidance. This leaves an implied guidance hurdle of just 3.3% yoy adj. EBIT growth in H2 (to c. € 38.5m), alongside 5.4% yoy sales growth (to c. € 471m), implying an 8.2% margin. While this requires the usual seasonal margin step-up from 7.1% in H1, the implied H2 margin would remain slightly below the 8.3% achieved last year. Hence, the FY guidance looks well within reach, without requiring a material acceleration in sales growth or further yoy margin expansion.

Meanwhile, neither of the sector's recent shocks has notable implications on GFT, in our view. IBM's miss sat in hardware, with Infrastructure down 7% yoy, while its Consulting line came in flat. At the same time, while Accenture is normally a fair cross-read, the group bookings decline of 3% yoy (fx-adj.) was attributable to two large managed services deals slipping into FY27. Importantly, consulting bookings were up for a fourth consecutive quarter. GFT sells into the same change budgets, and its core clients, banks and insurers across Europe and Latin America, are highly profitable and well-capitalised, with a modernisation backlog that is structural: ageing core platforms and now AI adoption forcing an overhaul of the systems underneath.

Meanwhile, recent sector M&A suggests GFT's share price understates the value of the business. Since June, two German-listed IT services peers have received all-cash takeover offers from strategic buyers at premiums of 94% and 105% to their respective three-month VWAPs. This implies valuations of c. 14x and c. 35x EV/EBIT (trailing 12-months). Persistent Systems is acquiring Nagarro, a digital engineering group of similar size to GFT at c. € 1bn sales. VINCI Energies is acquiring All for One, a German SAP services house, the same segment GFT has been building since the Megawork acquisition. Both had de-rated on soft German demand first, with All for One posting a 3% sales decline in its latest half-year. In contrast, GFT trades at c. 13x EV/EBIT (trailing 12-months), with earnings growth already reaccelerating.

Confirm BUY, PT unchanged at € 32, based on DCF. GFT is turning its strength in bank modernisation into margin, with adj. EBIT growing ahead of sales in Q1 and, on our estimates, again in Q2.
 

You can download the research here: gft-technologies-se-2026-07-29-previewreview-en-7d066
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2373160  29.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière